Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-L
![Toxic Epidermal Necrolysis Related to Pemetrexed and Carboplatin with Vitamin B12 and Folic Acid Supplementation for Advanced Non-Small Cell Lung Cancer | Semantic Scholar Toxic Epidermal Necrolysis Related to Pemetrexed and Carboplatin with Vitamin B12 and Folic Acid Supplementation for Advanced Non-Small Cell Lung Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7c7f608f323311f1df8893e48d314b8cf2c92507/3-Figure2-1.png)
Toxic Epidermal Necrolysis Related to Pemetrexed and Carboplatin with Vitamin B12 and Folic Acid Supplementation for Advanced Non-Small Cell Lung Cancer | Semantic Scholar
![Toxic Epidermal Necrolysis Related to Pemetrexed and Carboplatin with Vitamin B12 and Folic Acid Supplementation for Advanced Non-Small Cell Lung Cancer | Semantic Scholar Toxic Epidermal Necrolysis Related to Pemetrexed and Carboplatin with Vitamin B12 and Folic Acid Supplementation for Advanced Non-Small Cell Lung Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7c7f608f323311f1df8893e48d314b8cf2c92507/2-Figure1-1.png)
Toxic Epidermal Necrolysis Related to Pemetrexed and Carboplatin with Vitamin B12 and Folic Acid Supplementation for Advanced Non-Small Cell Lung Cancer | Semantic Scholar
![Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules | British Journal of Cancer Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6603995/MediaObjects/41416_2007_Article_BF6603995_Fig1_HTML.gif)
Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules | British Journal of Cancer
![Safe to Administer B12 Supplementation, Pemetrexed Infusions for Lung Cancers on Same Day - Oncology Nurse Advisor Safe to Administer B12 Supplementation, Pemetrexed Infusions for Lung Cancers on Same Day - Oncology Nurse Advisor](https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2019/01/lungg639617820rot_1368717.jpg)
Safe to Administer B12 Supplementation, Pemetrexed Infusions for Lung Cancers on Same Day - Oncology Nurse Advisor
![PDF) Effect of Folic Acid and Vitamin B12 on Pemetrexed Antifolate Chemotherapy in Nutrient Lung Cancer Cells PDF) Effect of Folic Acid and Vitamin B12 on Pemetrexed Antifolate Chemotherapy in Nutrient Lung Cancer Cells](https://i1.rgstatic.net/publication/256191064_Effect_of_Folic_Acid_and_Vitamin_B12_on_Pemetrexed_Antifolate_Chemotherapy_in_Nutrient_Lung_Cancer_Cells/links/618d4c6b3068c54fa5ceaaa5/largepreview.png)
PDF) Effect of Folic Acid and Vitamin B12 on Pemetrexed Antifolate Chemotherapy in Nutrient Lung Cancer Cells
A prospective observational study of on-treatment plasma homocysteine levels as a biomarker of toxicity, depression and vitamin supplementation lead-in time pre pemetrexed, in patients with non-small cell lung cancer and malignant mesothelioma
![Biology | Free Full-Text | Response of Human Glioblastoma Cells to Vitamin B12 Deficiency: A Study Using the Non-Toxic Cobalamin Antagonist Biology | Free Full-Text | Response of Human Glioblastoma Cells to Vitamin B12 Deficiency: A Study Using the Non-Toxic Cobalamin Antagonist](https://www.mdpi.com/biology/biology-10-00069/article_deploy/html/images/biology-10-00069-g001.png)
Biology | Free Full-Text | Response of Human Glioblastoma Cells to Vitamin B12 Deficiency: A Study Using the Non-Toxic Cobalamin Antagonist
![Timing of folic acid/vitamin B12 supplementation and hematologic toxicity during first‐line treatment of patients with nonsquamous non–small cell lung cancer using pemetrexed‐based chemotherapy: The PEMVITASTART randomized trial - Singh - 2019 - Timing of folic acid/vitamin B12 supplementation and hematologic toxicity during first‐line treatment of patients with nonsquamous non–small cell lung cancer using pemetrexed‐based chemotherapy: The PEMVITASTART randomized trial - Singh - 2019 -](https://acsjournals.onlinelibrary.wiley.com/cms/asset/63f21af4-3450-47a1-b2ed-0fb348bc64aa/cncr32028-fig-0002-m.jpg)
Timing of folic acid/vitamin B12 supplementation and hematologic toxicity during first‐line treatment of patients with nonsquamous non–small cell lung cancer using pemetrexed‐based chemotherapy: The PEMVITASTART randomized trial - Singh - 2019 -
![Frontiers | A Pilot Phase 1 Study of Intrathecal Pemetrexed for Refractory Leptomeningeal Metastases From Non-small-cell Lung Cancer Frontiers | A Pilot Phase 1 Study of Intrathecal Pemetrexed for Refractory Leptomeningeal Metastases From Non-small-cell Lung Cancer](https://www.frontiersin.org/files/MyHome%20Article%20Library/478981/478981_Thumb_400.jpg)
Frontiers | A Pilot Phase 1 Study of Intrathecal Pemetrexed for Refractory Leptomeningeal Metastases From Non-small-cell Lung Cancer
![Timing of folic acid/vitamin B12 supplementation and hematologic toxicity during first‐line treatment of patients with nonsquamous non–small cell lung cancer using pemetrexed‐based chemotherapy: The PEMVITASTART randomized trial - Singh - 2019 - Timing of folic acid/vitamin B12 supplementation and hematologic toxicity during first‐line treatment of patients with nonsquamous non–small cell lung cancer using pemetrexed‐based chemotherapy: The PEMVITASTART randomized trial - Singh - 2019 -](https://acsjournals.onlinelibrary.wiley.com/cms/asset/eee15250-34c6-4d71-871c-a2e25701b74d/cncr32028-fig-0001-m.jpg)